Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate Add-on for Depression in Palliative Cancer
NCT01497548Phase 3Unknown
- Sponsor
- Universiti Malaya
- Start
- Mar 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in major depressive disorder (MDD), sponsored by Universiti Malaya. Status: unknown.
02
Drugs
methylphenidate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01497548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497548.